# MRL Ventures Fund

MRL Ventures Fund is a Venture Capital based in Cambridge, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Cambridge, United States
- **Region:** North America
- **Address:** Cambridge, MA, United States
- **Founded:** 2014
- **Assets under management:** Undisclosed
- **Website:** www.mrlv.com
- **LinkedIn:** https://www.linkedin.com/company/mrl-ventures-fund-llc

## Regulatory record

- **Reports private funds:** No

## About

MRL Ventures Fund (MRLV) is the therapeutics-focused corporate venture group of MSD/Merck that partners with visionary founders pursuing breakthrough innovations and medicines to transform patient care. It invests globally in early-stage, preclinical therapeutics companies across modalities, providing capital, strategic guidance, board-level partnership and access to MSD’s domain expertise to accelerate development from concept to clinic. MRLV does not require product or technology rights as a condition of investment and focuses exclusively on therapeutics.

## Sectors

- Biotechnology
- Pharmaceuticals

## People

- Peter Dudek — President and Managing Partner
- Karin Kleinhans — Partner
- Olga Danilchanka — Partner
- Tao Fang — Senior Associate

## Questions

### Who runs investment decisions at MRL Ventures Fund?

Peter Dudek, Ph.D., is the President and Managing Partner and leads the investment team. He is the most senior decision-maker, supported by Partners Karin Kleinhans and Olga Danilchanka, and Senior Associate Tao Fang. The team’s background combines scientific research, operating, and prior venture investing experience.

### How does MRLV source deal flow, and does it rely on Merck's pipeline?

MRLV sources investments independently of Merck's internal R&D pipeline. The fund operates behind a stated firewall from the parent pharmaceutical company, and its team reviews external early-stage science globally. MRLV does not require a pre-existing Merck relationship for a company to receive investment.

### What is the maximum check size MRLV can write into a single company?

The fund states it can lead or co-lead rounds and deploy up to $25M in cumulative capital per company. This starts from initial investments at the concept or preclinical stage and extends through follow-on financings to key clinical inflection points.

### Does MRL Ventures Fund invest in medical devices or digital health?

No. MRLV explicitly limits its mandate to therapeutics — including small molecules, biologics, and cell therapies — and stated it does not invest in medical devices, diagnostic platforms, or digital health. For digital health, it points to a separate Merck vehicle, the Global Health Innovation Fund.

## Related profiles

- [Mraz, Amerine & Associates](https://altss.com/profile/mraz-amerine-associates)
- [MRM Asset Allocation Group](https://altss.com/profile/mrm-asset-allocation-group-inc)

---

Last updated: 2026-08-11T15:07:34.613Z

Canonical page: https://altss.com/profile/mrl-ventures-fund

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology